全文获取类型
收费全文 | 20107篇 |
免费 | 1321篇 |
国内免费 | 101篇 |
专业分类
耳鼻咽喉 | 258篇 |
儿科学 | 555篇 |
妇产科学 | 415篇 |
基础医学 | 3064篇 |
口腔科学 | 1291篇 |
临床医学 | 1607篇 |
内科学 | 4618篇 |
皮肤病学 | 526篇 |
神经病学 | 1667篇 |
特种医学 | 504篇 |
外国民族医学 | 1篇 |
外科学 | 2067篇 |
综合类 | 89篇 |
一般理论 | 6篇 |
预防医学 | 1946篇 |
眼科学 | 356篇 |
药学 | 1441篇 |
中国医学 | 116篇 |
肿瘤学 | 1002篇 |
出版年
2023年 | 163篇 |
2022年 | 452篇 |
2021年 | 722篇 |
2020年 | 475篇 |
2019年 | 650篇 |
2018年 | 718篇 |
2017年 | 541篇 |
2016年 | 580篇 |
2015年 | 636篇 |
2014年 | 873篇 |
2013年 | 1068篇 |
2012年 | 1591篇 |
2011年 | 1656篇 |
2010年 | 905篇 |
2009年 | 733篇 |
2008年 | 1163篇 |
2007年 | 1274篇 |
2006年 | 1086篇 |
2005年 | 1032篇 |
2004年 | 895篇 |
2003年 | 771篇 |
2002年 | 728篇 |
2001年 | 320篇 |
2000年 | 306篇 |
1999年 | 253篇 |
1998年 | 145篇 |
1997年 | 124篇 |
1996年 | 105篇 |
1995年 | 101篇 |
1994年 | 82篇 |
1993年 | 72篇 |
1992年 | 118篇 |
1991年 | 104篇 |
1990年 | 105篇 |
1989年 | 73篇 |
1988年 | 83篇 |
1987年 | 88篇 |
1986年 | 74篇 |
1985年 | 61篇 |
1984年 | 66篇 |
1983年 | 53篇 |
1982年 | 44篇 |
1981年 | 28篇 |
1980年 | 26篇 |
1979年 | 35篇 |
1978年 | 36篇 |
1974年 | 22篇 |
1970年 | 25篇 |
1967年 | 27篇 |
1966年 | 23篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
Iclea Rocha Gama Euclides Marinho Trindade-Filho Suzana Lima Oliveira Nassib Bezerra Bueno Isabelle Tenório Melo Cyro Rego Cabral-Junior Elenita M. Barros Jaqueline A. Galvão Wanessa S. Pereira Raphaela C. Ferreira Bruna R. Domingos Terezinha da Rocha Ataide 《Metabolic brain disease》2015,30(1):93-98
6.
José Antonio Pereira Miguel Pera Manuel López-Cano Marta Pascual Sandra Alonso Silvia Salvans Marta Jiménez-Toscano Alba González-Martín Luis Grande-Posa 《Cirugía espa?ola》2019,97(1):20-26
Objectives
To determine the incidence of incisional hernia (IH) in the extraction incision (EI) in colorectal resection for cancer. To analyze whether the location of the incision has any relationship with the incidence of hernias and whether mesh could be useful for prevention in high-risk patients.Methods
Retrospective review of the colon and rectal surgery database from January 2015 to December 2016. Data were classified into 2 groups, transverse (TI) and midline incision (MI), and the latter was divided into 2 subgroups (mesh [MIM] and suture [MIS]). Patients were classified using the HERNIAscore. Hernias were diagnosed by clinical and/or CT examination.Results
A total of 182 out of 210 surgical patients were included. After a median follow-up of 13.0 months, 39 IH (21.9%) were detected, 23 of which (13.4%) were in the EI; their frequency was lower in the TI group (3.4%) and in the MIM group (5.9%) than in the MIS group (29.5%; p = 0.007). The probability of developing IH in the MIS group showed an OR = 11.7 (95%CI: 3.3-42.0) compared to the TI group and 4.3 (IC 95%: 1.1-16.3) versus the MIM group.Conclusions
The location of the incision is relevant to avoid incisional hernias. Transverse incisions should be used as the first option. When a midline incision is needed, a prophylactic mesh could be considered in high risk patients because it is safe and associated with low morbidity. 相似文献7.
8.
Flavia Temperilli Aldona Rina Isabella Massimi Anna Lisa Montemari Maria Luisa Guarino Alessandra Zicari 《Platelets》2015,26(8):783-787
Serum thromboxane-B2 (TxB2), together with arachidonic acid (AA)-induced platelet aggregation, are, at the moment, the most used tests to identify patients displaying high on-aspirin treatment platelet reactivity (HAPR). Both tests are specific for aspirin action on cyclooxygenase-1. While the correlation between serum TxB2 assay and clinical outcome is established, data are conflicting with regard to aspirin treatment and a possible association with AA-stimulated platelet markers and clinical outcome. To understand such discrepancy, we performed a retrospective study to compare both assays. We collected data from 132 patients receiving a daily dose of aspirin (100?mg/day) and data from 48 patients receiving aspirin on alternate days. All Patients who received a daily dose of aspirin were studied for AA-induced platelet aggregation together with serum TxB2 levels and AA-induced TxB2 formation was also studied in 71 patients out of entire population. Consistent with recommendations in the literature, we defined HAPR by setting a cut-off point at 3.1?ng/ml for serum levels of thromboxane B2 and 20% for AA-induced platelet aggregation. According to this cut-off point, we divided our overall population into two groups: (1) TxB2?<?3.1?ng/ml and (2) TxB2?>?3.1?ng/ml. We found low agreement between such tests to identify patients displaying HAPR. Our results show that AA-induced platelet aggregation >20% identify a smaller number of HAPR patients in comparison with TxB2. A good correlation between serum TxB2 and arachidonic acid-induced TxB2 production was found (r?=?0.76619). 相似文献
9.